RNA 測序市場：第 2 版

測序市場繼續提供強大的工具，具有徹底改變醫學的潛力。在過去的十年中，產品推出、新應用程序和急於進入這些新領域的最終用戶實驗室出現了爆炸性增長。近年來，隨著 RNA 測序的不斷取代和取代，用於 RNA 表達分析的微陣列的使用顯著下降。

本報告側重於 RNA 測序產品（硬件、硬件服務、軟件和消耗品，包括測序步驟本身）市場，討論趨勢、挑戰、戰略、公司和產品。提供市場份額和收入增長的估計。

調查詳情：

• RNA 測序市場 (2021/2026)
• RNA 測序耗材市場 (2021/2026)
• RNA測序設備相關服務市場（2021、2026）
• RNA測序軟件市場（2021/2026）
• RNA 測序供應商份額
• 已上市產品
• 軟件產品
• 創新
• 臨床測序和上市產品

內容

第 1 章執行摘要

第 2 章市場趨勢

• 簡介
• 趨勢
• 用於臨床診斷和臨床研究
• 癌症 - 白血病/血液病、實體瘤
• 感染
• 罕見的遺傳/遺傳疾病
• COVID-19
• 多樣化的 Illumina 產品組合
• 來自其他公司的 NGS 產品和技術
• CDC SPHERE 聯盟
• 不斷推出新產品
• 單細胞 RNA 測序
• 主要產品/技術
• 軟件/生物信息學
• 多個領域的合作、收購和交易

第三章市場分析

• 市場分析
• 市場份額

第四章公司簡介

• Illumina
• Thermo Fisher Scientific
• New England Biolabs
• 10X Genomics
• Agilent Technologies
• Takara Bio Inc.
• Oxford Nanopore Technologies
• NuGen (Tecan)
• Pacific Biosciences of California, Inc. (PacBio)
• Standard BioTools

The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it. Similar to quantitative reverse transcription-PCR (q-RT-PCR) which has been the gold standard, there is a need for pre-defined probes which creates one of the major weaknesses of microarrays, and RNA-seq provides a number of advantages including:

• improved sensitivity and dynamic range

• ability to study species without reference

• measurement of focal changes (such as single nucleotide variants, insertions and deletions)

• detection of different transcript isoforms, splice variants and chimeric gene fusions (including previously unidentified genes and/or transcripts)

This report, “The Market for RNA Sequencing, 2nd Edition ”, focuses on the market for RNA sequencing products - the hardware, service of the hardware, software, and consumables including for the sequencing step itself. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market.

Information in this report includes:

• RNA Sequencing Market, 2021 and 2026

• RNA Sequencing Consumables Market, 2021 and 2026

• RNA Sequencing Equipment-Related Services Market, 2021 and 2026

• RNA Sequencing Software Market, 2021 and 2026

• RNA Sequencing Vendor Share

• Products on The Market

• Software Products

• Innovations

• Clinical Sequencing and Products on the Market

The competitive situation, deals, and litigation are covered in respective chapters. The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

Companies Profiled Include:

• Illumina
• Agilent
• 10X Genomics
• Oxford Nanopore
• Thermo
• Roche
• Qiagen
• and Others

Table of Contents

Chapter 1: Executive Summary

• Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (in millions of $)
• Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
• Scope and Methodology
• Report Structure

Chapter 2: Market Trends

• Introduction
• Trends
• Clinical Diagnostics, Clinical Research Applications
• Cancer - leukemia/ hematological diseases; solid tumors
• Infectious diseases
• Rare inherited/ genetic diseases
  • Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies
• COVID-19
• Illumina's Diverse Range of Products
• Other Companies' NGS Products and Technologies
• CDC's SPHERES Consortium
• Ongoing Introductions of New Products
  • Table 2-2: RNA-Sequencing Product Introductions, August 2017- August 2022
• Single-Cell RNA Sequencing
• Selected Products/ Technologies
  • Table 2-3: Selected RNA-Seq Products and Technologies
• Software/ Bioinformatics
  • Table 2-4: Selected RNA-Seq Software and Related IT Tools
• Partnerships, Acquisitions, Deals in Many Areas
  • Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals

Chapter 3: Market Analysis

• Market Analysis
  • Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
  • Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
  • Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (percent)
  • Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
• Market Shares
  • Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2021 (millions of dollars and percent)
  • Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
  • Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
  • Figure 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)

Chapter 4: Company Profiles

• Illumina
• Thermo Fisher Scientific
• New England Biolabs
• 10X Genomics
• Agilent Technologies
• Takara Bio Inc.
• Oxford Nanopore Technologies
• NuGen (Tecan)
• Pacific Biosciences of California, Inc. (PacBio)
• Standard BioTools